| GS follow link to MSigDB | GS DETAILS | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val | RANK AT MAX | LEADING EDGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CL23065, IONOTROPIC GLUTAMATE RECEPTOR, AND NEUROTRANSMITTER RECEPTOR TRANSPORT, POSTSYNAPTIC ENDOSOME TO LYSOSOME | Details ... | 16 | 0.83 | 1.39 | 0.007 | 0.220 | 0.201 | 228 | tags=13%, list=1%, signal=13% |
| 2 | CL6926, DEFECTIVE BINDING OF RB1 MUTANTS TO E2F1,(E2F2, E2F3) | Details ... | 10 | 0.82 | 1.34 | 0.030 | 0.330 | 0.498 | 2569 | tags=20%, list=14%, signal=23% |
| 3 | CL17673, MIXED, INCL. INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS, AND CARDIOFACIOCUTANEOUS SYNDROME | Details ... | 25 | 0.76 | 1.31 | 0.006 | 0.349 | 0.668 | 1423 | tags=24%, list=8%, signal=26% |
| 4 | CL22980, NEUREXINS AND NEUROLIGINS, AND REGULATION OF PRESYNAPSE ASSEMBLY | Details ... | 36 | 0.75 | 1.31 | 0.006 | 0.273 | 0.680 | 2597 | tags=17%, list=14%, signal=19% |
| 5 | CL5428, PR-DUB COMPLEX, AND METHYL-CPG-BINDING DOMAIN PROTEIN 5|6 | Details ... | 10 | 0.80 | 1.31 | 0.050 | 0.229 | 0.698 | 1782 | tags=30%, list=10%, signal=33% |
| 6 | CL2173, U2-TYPE CATALYTIC STEP 2 SPLICEOSOME | Details ... | 16 | 0.76 | 1.28 | 0.049 | 0.271 | 0.808 | 2554 | tags=25%, list=14%, signal=29% |
| 7 | CL22984, NEUREXINS AND NEUROLIGINS | Details ... | 20 | 0.74 | 1.27 | 0.028 | 0.276 | 0.861 | 2597 | tags=15%, list=14%, signal=18% |
| 8 | CL5108, NPBAF COMPLEX | Details ... | 10 | 0.77 | 1.26 | 0.088 | 0.291 | 0.905 | 492 | tags=10%, list=3%, signal=10% |
| 9 | CL22979, NEUROTRANSMITTER RECEPTOR COMPLEX, AND NEUREXINS AND NEUROLIGINS | Details ... | 73 | 0.68 | 1.22 | 0.004 | 0.444 | 0.987 | 1295 | tags=11%, list=7%, signal=12% |
| 10 | CL17676, NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY, AND RAS GTPASE CYCLE MUTANTS | Details ... | 14 | 0.73 | 1.21 | 0.131 | 0.483 | 0.996 | 1423 | tags=21%, list=8%, signal=23% |
| 11 | CL8032, PROTEIN PHOSPHATASE TYPE 2A COMPLEX | Details ... | 18 | 0.71 | 1.21 | 0.102 | 0.446 | 0.996 | 666 | tags=11%, list=4%, signal=12% |
| 12 | CL29117, YD REPEAT, AND GPCR, FAMILY 2, LATROPHILIN | Details ... | 11 | 0.72 | 1.19 | 0.186 | 0.513 | 0.998 | 3431 | tags=27%, list=19%, signal=34% |
| 13 | CL5099, SWI|SNF COMPLEX | Details ... | 29 | 0.68 | 1.18 | 0.091 | 0.487 | 0.998 | 3745 | tags=21%, list=21%, signal=26% |
| 14 | CL22730, JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE, AND TERMINAL CISTERNA | Details ... | 13 | 0.71 | 1.18 | 0.167 | 0.460 | 0.999 | 1724 | tags=15%, list=10%, signal=17% |
| 15 | CL17474, PHOSPHATIDYLINOSITOL 3-KINASE COMPLEX, CLASS I, AND INSULIN RECEPTOR COMPLEX | Details ... | 18 | 0.70 | 1.18 | 0.151 | 0.440 | 0.999 | 2220 | tags=22%, list=12%, signal=25% |
| 16 | CL21447, CANONICAL AND NON-CANONICAL NOTCH SIGNALING | Details ... | 13 | 0.69 | 1.14 | 0.234 | 0.594 | 0.999 | 4535 | tags=31%, list=25%, signal=41% |
| 17 | CL2170, U2-TYPE CATALYTIC STEP 2 SPLICEOSOME, AND SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | Details ... | 24 | 0.65 | 1.12 | 0.221 | 0.699 | 1.000 | 3418 | tags=25%, list=19%, signal=31% |
| 18 | CL2141, PRESPLICEOSOME | Details ... | 11 | 0.67 | 1.11 | 0.302 | 0.698 | 1.000 | 2233 | tags=18%, list=12%, signal=21% |
| 19 | CL4976, MLL3|4 COMPLEX, AND HISTONE H3-K4 DIMETHYLATION | Details ... | 14 | 0.67 | 1.11 | 0.289 | 0.668 | 1.000 | 965 | tags=7%, list=5%, signal=8% |
| 20 | CL2035, U2-TYPE SPLICEOSOMAL COMPLEX, AND MRNA SPLICING - MAJOR PATHWAY | Details ... | 98 | 0.60 | 1.09 | 0.130 | 0.739 | 1.000 | 4541 | tags=26%, list=25%, signal=34% |
| 21 | CL2044, U4|U6 X U5 TRI-SNRNP COMPLEX | 12 | 0.65 | 1.08 | 0.371 | 0.758 | 1.000 | 853 | tags=8%, list=5%, signal=9% | |
| 22 | CL21442, CANONICAL AND NON-CANONICAL NOTCH SIGNALING, AND FRINGE | 24 | 0.63 | 1.07 | 0.352 | 0.765 | 1.000 | 4535 | tags=25%, list=25%, signal=33% | |
| 23 | CL10567, PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS, AND URIDINE-DIPHOSPHATASE ACTIVITY | 29 | 0.62 | 1.07 | 0.327 | 0.751 | 1.000 | 4385 | tags=45%, list=24%, signal=59% | |
| 24 | CL17470, GPVI-MEDIATED ACTIVATION CASCADE, AND SH2 DOMAIN SUPERFAMILY | 62 | 0.60 | 1.07 | 0.264 | 0.726 | 1.000 | 3191 | tags=19%, list=18%, signal=23% | |
| 25 | CL17473, MIXED, INCL. SIGNALING BY ERYTHROPOIETIN, AND INSULIN RECEPTOR COMPLEX | 33 | 0.61 | 1.07 | 0.342 | 0.702 | 1.000 | 2220 | tags=15%, list=12%, signal=17% | |
| 26 | CL5104, NPBAF COMPLEX, AND H3K9ME3 MODIFIED HISTONE BINDING | 15 | 0.63 | 1.07 | 0.372 | 0.678 | 1.000 | 4909 | tags=20%, list=27%, signal=27% | |
| 27 | CL9002, HYDROGEN SULFIDE METABOLIC PROCESS, AND S-ADENOSYLMETHIONINE METABOLIC PROCESS | 14 | 0.63 | 1.06 | 0.392 | 0.685 | 1.000 | 1443 | tags=14%, list=8%, signal=16% | |
| 28 | CL8029, MAGNESIUM-DEPENDENT PROTEIN SERINE|THREONINE PHOSPHATASE COMPLEX, AND CALCIPRESSIN | 36 | 0.60 | 1.05 | 0.349 | 0.696 | 1.000 | 2643 | tags=14%, list=15%, signal=16% | |
| 29 | CL21437, MIXED, INCL. NOTCH SIGNALING PATHWAY, AND AMYLOID A4 | 59 | 0.59 | 1.04 | 0.340 | 0.709 | 1.000 | 2701 | tags=17%, list=15%, signal=20% | |
| 30 | CL2036, SPLICEOSOMAL SNRNP COMPLEX, AND MRNA CIS SPLICING, VIA SPLICEOSOME | 60 | 0.58 | 1.04 | 0.368 | 0.693 | 1.000 | 2233 | tags=12%, list=12%, signal=13% | |
| 31 | CL2038, PRECATALYTIC SPLICEOSOME, AND U4|U6 X U5 TRI-SNRNP COMPLEX | 41 | 0.59 | 1.04 | 0.387 | 0.673 | 1.000 | 1644 | tags=10%, list=9%, signal=11% | |
| 32 | CL8579, FRUCTOSE AND MANNOSE METABOLISM | 19 | 0.61 | 1.04 | 0.439 | 0.672 | 1.000 | 3273 | tags=32%, list=18%, signal=39% | |
| 33 | CL8578, GLYCOLYSIS, AND SUGAR-PHOSPHATASE ACTIVITY | 33 | 0.60 | 1.04 | 0.419 | 0.652 | 1.000 | 4237 | tags=42%, list=24%, signal=55% | |
| 34 | CL13677, TRAPP COMPLEX | 16 | 0.60 | 1.02 | 0.493 | 0.684 | 1.000 | 3769 | tags=31%, list=21%, signal=39% | |
| 35 | CL10570, URIDINE-DIPHOSPHATASE ACTIVITY, AND PURINE RIBONUCLEOTIDE SALVAGE | 17 | 0.60 | 1.02 | 0.479 | 0.686 | 1.000 | 5643 | tags=59%, list=31%, signal=86% | |
| 36 | CL17475, PHOSPHATIDYLINOSITOL 3-KINASE COMPLEX, CLASS I, AND INSULIN RECEPTOR SUBSTRATE | 12 | 0.59 | 0.97 | 0.597 | 0.834 | 1.000 | 2220 | tags=17%, list=12%, signal=19% | |
| 37 | CL2040, U2-TYPE PRECATALYTIC SPLICEOSOME | 24 | 0.56 | 0.96 | 0.641 | 0.828 | 1.000 | 853 | tags=8%, list=5%, signal=9% | |
| 38 | CL6643, CHROMOSOME PASSENGER COMPLEX, AND OUTER KINETOCHORE | 11 | 0.58 | 0.95 | 0.635 | 0.845 | 1.000 | 3274 | tags=27%, list=18%, signal=33% | |
| 39 | CL34187, DESMOSOME, AND ICHTHYOSIS VULGARIS | 23 | 0.53 | 0.92 | 0.695 | 0.890 | 1.000 | 7200 | tags=65%, list=40%, signal=109% | |
| 40 | CL10910, NICOTINATE AND NICOTINAMIDE METABOLISM | 15 | 0.53 | 0.89 | 0.732 | 0.935 | 1.000 | 3441 | tags=20%, list=19%, signal=25% | |
| 41 | CL10681, INTERCONVERSION OF NUCLEOTIDE DI- AND TRIPHOSPHATES, AND UTP METABOLIC PROCESS | 22 | 0.51 | 0.88 | 0.773 | 0.924 | 1.000 | 5966 | tags=36%, list=33%, signal=54% | |
| 42 | CL5066, INO80 COMPLEX | 10 | 0.52 | 0.85 | 0.767 | 0.953 | 1.000 | 6796 | tags=40%, list=38%, signal=64% | |
| 43 | CL34216, NAXOS DISEASE, AND SUBCORNEAL PUSTULAR DERMATOSIS | 11 | 0.50 | 0.83 | 0.765 | 0.964 | 1.000 | 7605 | tags=73%, list=42%, signal=126% | |
| 44 | CL19594, INTEGRIN DOMAIN SUPERFAMILY | 11 | 0.47 | 0.79 | 0.823 | 0.987 | 1.000 | 5479 | tags=36%, list=30%, signal=52% | |
| 45 | CL17509, DOWNSTREAM SIGNAL TRANSDUCTION, AND GRB2-ASSOCIATED-BINDING PROTEIN 1-4-LIKE | 15 | 0.41 | 0.68 | 0.947 | 1.000 | 1.000 | 8280 | tags=40%, list=46%, signal=74% | |
| 46 | CL5268, ISWI-TYPE COMPLEX, AND BRK DOMAIN | 21 | 0.38 | 0.65 | 0.970 | 1.000 | 1.000 | 1145 | tags=5%, list=6%, signal=5% | |
| 47 | CL18402, MIXED, INCL. MAP KINASE ACTIVITY, AND PROTEIN TYROSINE|THREONINE PHOSPHATASE ACTIVITY | 30 | 0.38 | 0.65 | 0.991 | 1.000 | 1.000 | 6610 | tags=27%, list=37%, signal=42% | |
| 48 | CL25158, ATP P2X RECEPTOR, AND G PROTEIN-COUPLED UTP RECEPTOR ACTIVITY | 12 | 0.34 | 0.56 | 0.981 | 1.000 | 1.000 | 5033 | tags=25%, list=28%, signal=35% | |
| 49 | CL25156, NUCLEOTIDE RECEPTOR ACTIVITY | 17 | 0.31 | 0.54 | 0.996 | 0.992 | 1.000 | 9833 | tags=59%, list=55%, signal=129% |